Skip to content

Subcutaneous Nitroglycerin for Pediatric Radial Artery Cannulation

The Effect of Subcutaneous Nitroglycerin on the Success Rate of Arterial Catheterization in Pediatric Patients: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03849183
Enrollment
116
Registered
2019-02-21
Start date
2019-03-20
Completion date
2019-07-22
Last updated
2019-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Line

Keywords

Radial Artery, Vascular Catheters

Brief summary

The primary objective of the study is to evaluate the vasodilative effect of subcutaneous nitroglycerin during ultrasound-guided radial artery cannulation in pediatric patients. The hypothesis of this study is that the subcutaneous nitroglycerin will increase the radial artery size and improve the first-attempt success rate of radial artery cannulation. This is a single-center, double-blind, randomized, placebo-controlled study comparing the effect of subcutaneous nitroglycerin and saline on radial artery cannulation in pediatric patients undergoing general anesthesia. Prior to the procedure, each patient will be randomized into either the control arm, saline, or study arm, nitroglycerin.

Interventions

DRUGNitroglycerin

Subcutaneous nitroglycerin injection to increase the first attempt success rate of radial artery cannulation in pediatric patients

DRUGNormal saline

Subcutaneous normal saline injection to increase the first attempt success rate of radial artery cannulation in pediatric patients

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
No minimum to 2 Years
Healthy volunteers
No

Inclusion criteria

* General anesthesia * Arterial cannulation for hemodynamic monitoring, multiple blood sample

Exclusion criteria

* Hypersensitivity or contraindication to nitroglycerine * Unstable vital sign, significant arrhythmia or hypotension, Shock * High risk of peripheral ischemia * Skin disease, infection, hematoma, recent cannulation at radial artery. * Increased intracranial pressure, Intracranial hemorrhage * Glaucoma * Recent use of PDE5 inhibitors (\<24 hours after sildenafil or vardenafil; \<48 hours after tadalafil)

Design outcomes

Primary

MeasureTime frameDescription
First attempt success rateDuring radial artery cannulation (up to 1 hour)Success at the first skin puncture

Secondary

MeasureTime frameDescription
depth of radial arteryBefore and after subcutaneous injection of drugs (up to 1 hour)depth of radial artery from the skin
Overall attemptDuring radial artery cannulation (up to 1 hour)Number of attempt of radial artery cannulation
Overall Procedure timeDuring radial artery cannulation (up to 1 hour)From ultrasound guidance, to Arterial waveform
Size of radial arteryBefore and after subcutaneous injection of drugs (up to 1 hour)Internal diameter of radial artery
Malfunction of radial artery catheterAfter radial artery cannulation assessed during anesthesia (up to 24 hour)Invasive blood pressure monitoring, Sampling
Complication rateAfter radial artery cannulation assessed up to PACU, PICU stay (per 24hour, up to 48 hour)Hematoma, Distal ischemia, Spasm accessed by ultrasound
Overall success rateDuring radial artery cannulation (up to 1 hour)Success within 4 skin puncture (2 skin puncture at each radial artery)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026